Search Share Prices
GSK News - Chronic Kidney Disease Drugs Market Expected to Grow at a CAGR of 4.5% by 2027|AstraZeneca, Amgen Inc., Pfizer Inc.
Research Nester released a report titled "Chronic Kidney Disease Drugs Market: Global Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the global chronic kidney disease ...
Liberum Capital Reiterates “Hold” Rating for GlaxoSmithKline (LON:GSK)
GlaxoSmithKline (LON:GSK)‘s stock had its “hold” rating restated by equities researchers at Liberum Capital in a report released on Wednesday, ThisIsMoney.Co.Uk reports. GSK has been the topic of a ...
Antacids Market Global Upcoming Demand & Growth Analysis Up To 2025
New York, March 18, 2020: The Global Antacids Market is expected to exceed more than US$ 10.317 Billion by 2024 at a CAGR of 3.74 % in the given forecast period. The report scope includes detailed ...
Does GlaxoSmithKline plc's (LON:GSK) CEO Salary Reflect Performance?
since 2017. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. Next, we'll consider growth that the business demonstrates. And ...
Barclays Trims GlaxoSmithKline (LON:GSK) Target Price to GBX 1,450
GlaxoSmithKline (LON:GSK) had its price objective reduced by Barclays from GBX 1,550 ($20.39) to GBX 1,450 ($19.07) in a research report issued to clients and investors on Tuesday, ThisIsMoney.Co.Uk ...